Imunon, Inc. Realized Investment Gains (Losses)
Imunon, Inc. (IMNN) reported Realized Investment Gains (Losses) of $58.07 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2019-11-14
- Imunon, Inc. realized investment gains (losses) for the quarter ending 2019-09-30 was $58.07K, a 1982.78% increase year-over-year.
- Imunon, Inc. realized investment gains (losses) for the quarter ending 2019-06-30 was $969.00, a 75.17% decline year-over-year.
- Imunon, Inc. realized investment gains (losses) for the quarter ending 2019-03-31 was $9.38K, a 111.52% increase year-over-year.
- Imunon, Inc. realized investment gains (losses) for the quarter ending 2018-09-30 was $2.79K.
- Imunon, Inc. realized investment gains (losses) for fiscal 2012 was $52.32B, a 62.04% increase from fiscal 2011.
- Imunon, Inc. realized investment gains (losses) for fiscal 2011 was $32.29B, a 30.05% decline from fiscal 2010.
- Imunon, Inc. realized investment gains (losses) for fiscal 2010 was $46.16B.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $58.07K 10-Q · filed 2019-11-14 | $59.04K derived: sum of 2 quarters · filed 2019-11-14 | $68.42K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $969.00 10-Q · filed 2019-08-14 | $10.35K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $9.38K 10-Q · filed 2019-05-15 | |||
| 2018-09-30 | $2.79K 10-Q · filed 2019-11-14 | $6.69K derived: sum of 2 quarters · filed 2019-11-14 | $11.13K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $3.90K 10-Q · filed 2019-08-14 | $8.34K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $4.43K 10-Q · filed 2019-05-15 | |||
| 2014-06-30 | $23.73K 10-Q · filed 2014-08-07 | $30.75K 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | $7.02K 10-Q · filed 2014-05-08 | |||
| 2013-09-30 | $144.53K 10-Q · filed 2013-11-12 | $211.66K derived: sum of 2 quarters · filed 2014-08-07 | $228.23K 10-Q · filed 2013-11-12 | $52.32B derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-06-30 | $67.13K 10-Q · filed 2014-08-07 | $83.69K 10-Q · filed 2014-08-07 | $52.32B derived: sum of 3 quarters · filed 2014-08-07 | $52.32B derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $16.56K 10-Q · filed 2014-05-08 | $52.32B derived: sum of 2 quarters · filed 2014-05-08 | $52.32B derived: sum of 3 quarters · filed 2014-05-08 | $52.32B derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $52.32B derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $52.32B derived: sum of 2 quarters · filed 2013-11-12 | $52.32B derived: sum of 3 quarters · filed 2013-11-12 | $52.32B 10-K · filed 2013-03-18 |
| 2012-09-30 | -$5.58K 10-Q · filed 2013-11-12 | $56.49K derived: sum of 2 quarters · filed 2013-11-12 | $61.83K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $62.08K 10-Q · filed 2013-08-08 | $67.41K 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $5.33K 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | $32.29B 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $46.16B 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |